From July 1, 2023 to September 30, 2023, the company has repurchased 0 shares, representing 0% for CNY 0 million. With this, the company has completed the repurchase of 421,100 shares, representing 0.25% for CNY 5.07 million under the buyback announced on May 9, 2023.
End-of-day quote
Other stock markets
|
5-day change | 1st Jan Change | ||
10.17 CNY | -0.29% | -1.83% | -30.20% |
1st Jan change | Capi. | |
---|---|---|
-30.20% | 237M | |
+13.80% | 8.17B | |
+0.47% | 7.31B | |
-8.08% | 5.43B | |
-6.72% | 3.69B | |
-19.73% | 3.2B | |
-12.00% | 1.21B | |
-26.74% | 1.12B | |
-14.98% | 868M | |
+0.89% | 868M |
- Stock Market
- Equities
- 603079 Stock
- News Zhejiang Shengda Bio-Pharm Co., Ltd.
- Tranche Update on Zhejiang Shengda Bio-Pharm Co., Ltd.'s Equity Buyback Plan announced on May 9, 2023.